282 related articles for article (PubMed ID: 28832116)
41. Development and crystallographic evaluation of histone H3 peptide with N-terminal serine substitution as a potent inhibitor of lysine-specific demethylase 1.
Amano Y; Kikuchi M; Sato S; Yokoyama S; Umehara T; Umezawa N; Higuchi T
Bioorg Med Chem; 2017 May; 25(9):2617-2624. PubMed ID: 28336409
[TBL] [Abstract][Full Text] [Related]
42. Lysine-Specific Histone Demethylase 1A Regulates Macrophage Polarization and Checkpoint Molecules in the Tumor Microenvironment of Triple-Negative Breast Cancer.
Tan AHY; Tu W; McCuaig R; Hardy K; Donovan T; Tsimbalyuk S; Forwood JK; Rao S
Front Immunol; 2019; 10():1351. PubMed ID: 31249575
[TBL] [Abstract][Full Text] [Related]
43. Highly effective combination of LSD1 (KDM1A) antagonist and pan-histone deacetylase inhibitor against human AML cells.
Fiskus W; Sharma S; Shah B; Portier BP; Devaraj SG; Liu K; Iyer SP; Bearss D; Bhalla KN
Leukemia; 2014 Nov; 28(11):2155-64. PubMed ID: 24699304
[TBL] [Abstract][Full Text] [Related]
44. Antagonistic actions of Rcor proteins regulate LSD1 activity and cellular differentiation.
Upadhyay G; Chowdhury AH; Vaidyanathan B; Kim D; Saleque S
Proc Natl Acad Sci U S A; 2014 Jun; 111(22):8071-6. PubMed ID: 24843136
[TBL] [Abstract][Full Text] [Related]
45. Structural basis of histone demethylation by LSD1 revealed by suicide inactivation.
Yang M; Culhane JC; Szewczuk LM; Gocke CB; Brautigam CA; Tomchick DR; Machius M; Cole PA; Yu H
Nat Struct Mol Biol; 2007 Jun; 14(6):535-9. PubMed ID: 17529991
[TBL] [Abstract][Full Text] [Related]
46. A novel mammalian flavin-dependent histone demethylase.
Karytinos A; Forneris F; Profumo A; Ciossani G; Battaglioli E; Binda C; Mattevi A
J Biol Chem; 2009 Jun; 284(26):17775-82. PubMed ID: 19407342
[TBL] [Abstract][Full Text] [Related]
47. Histone demethylation catalysed by LSD1 is a flavin-dependent oxidative process.
Forneris F; Binda C; Vanoni MA; Mattevi A; Battaglioli E
FEBS Lett; 2005 Apr; 579(10):2203-7. PubMed ID: 15811342
[TBL] [Abstract][Full Text] [Related]
48. LSD1 collaborates with EZH2 to regulate expression of interferon-stimulated genes.
Jin Y; Huo B; Fu X; Hao T; Zhang Y; Guo Y; Hu X
Biomed Pharmacother; 2017 Apr; 88():728-737. PubMed ID: 28152483
[TBL] [Abstract][Full Text] [Related]
49. Cooperative demethylation by JMJD2C and LSD1 promotes androgen receptor-dependent gene expression.
Wissmann M; Yin N; Müller JM; Greschik H; Fodor BD; Jenuwein T; Vogler C; Schneider R; Günther T; Buettner R; Metzger E; Schüle R
Nat Cell Biol; 2007 Mar; 9(3):347-53. PubMed ID: 17277772
[TBL] [Abstract][Full Text] [Related]
50. SUMOylation negatively modulates target gene occupancy of the KDM5B, a histone lysine demethylase.
Bueno MT; Richard S
Epigenetics; 2013 Nov; 8(11):1162-75. PubMed ID: 23970103
[TBL] [Abstract][Full Text] [Related]
51. Histone demethylation mediated by the nuclear amine oxidase homolog LSD1.
Shi Y; Lan F; Matson C; Mulligan P; Whetstine JR; Cole PA; Casero RA; Shi Y
Cell; 2004 Dec; 119(7):941-53. PubMed ID: 15620353
[TBL] [Abstract][Full Text] [Related]
52. Chemically ubiquitylated histone H2B stimulates hDot1L-mediated intranucleosomal methylation.
McGinty RK; Kim J; Chatterjee C; Roeder RG; Muir TW
Nature; 2008 Jun; 453(7196):812-6. PubMed ID: 18449190
[TBL] [Abstract][Full Text] [Related]
53. Design, Synthesis, and In Vitro Evaluation of Novel Histone H3 Peptide-Based LSD1 Inactivators Incorporating α,α-Disubstituted Amino Acids with γ-Turn-Inducing Structures.
Ota Y; Kakizawa T; Itoh Y; Suzuki T
Molecules; 2018 May; 23(5):. PubMed ID: 29734782
[TBL] [Abstract][Full Text] [Related]
54. MOF Acetylates the Histone Demethylase LSD1 to Suppress Epithelial-to-Mesenchymal Transition.
Luo H; Shenoy AK; Li X; Jin Y; Jin L; Cai Q; Tang M; Liu Y; Chen H; Reisman D; Wu L; Seto E; Qiu Y; Dou Y; Casero RA; Lu J
Cell Rep; 2016 Jun; 15(12):2665-78. PubMed ID: 27292636
[TBL] [Abstract][Full Text] [Related]
55. Phosphorylation of neuronal Lysine-Specific Demethylase 1LSD1/KDM1A impairs transcriptional repression by regulating interaction with CoREST and histone deacetylases HDAC1/2.
Toffolo E; Rusconi F; Paganini L; Tortorici M; Pilotto S; Heise C; Verpelli C; Tedeschi G; Maffioli E; Sala C; Mattevi A; Battaglioli E
J Neurochem; 2014 Mar; 128(5):603-16. PubMed ID: 24111946
[TBL] [Abstract][Full Text] [Related]
56. 8 Demethylation pathways for histone methyllysine residues.
Forneris F; Binda C; Vanoni M; Mattevi A; Battagliol E
Enzymes; 2006; 24():229-42. PubMed ID: 26718042
[TBL] [Abstract][Full Text] [Related]
57. Class I lysine deacetylases promote glucocorticoid-induced transcriptional repression through functional interaction with LSD1.
Patrick NM; Griggs CA; Icenogle AL; Gilpatrick MM; Kadiyala V; Jaime-Frias R; Smith CL
J Steroid Biochem Mol Biol; 2017 Mar; 167():1-13. PubMed ID: 27645313
[TBL] [Abstract][Full Text] [Related]
58. Differential properties of transcriptional complexes formed by the CoREST family.
Barrios ÁP; Gómez AV; Sáez JE; Ciossani G; Toffolo E; Battaglioli E; Mattevi A; Andrés ME
Mol Cell Biol; 2014 Jul; 34(14):2760-70. PubMed ID: 24820421
[TBL] [Abstract][Full Text] [Related]
59. Sumoylation of CoREST modulates its function as a transcriptional repressor.
Muraoka A; Maeda A; Nakahara N; Yokota M; Nishida T; Maruyama T; Ohshima T
Biochem Biophys Res Commun; 2008 Dec; 377(4):1031-5. PubMed ID: 18854179
[TBL] [Abstract][Full Text] [Related]
60. Long noncoding RNA as modular scaffold of histone modification complexes.
Tsai MC; Manor O; Wan Y; Mosammaparast N; Wang JK; Lan F; Shi Y; Segal E; Chang HY
Science; 2010 Aug; 329(5992):689-93. PubMed ID: 20616235
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]